Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin‐converting enzyme 2

• Hauptverfasser: Kyungmin Lee (Verfasst von), Yujeong Na (Verfasst von), Minjin Kim (Verfasst von), Dongjin Lee (Verfasst von), Jongseo Choi (Verfasst von), Gwanyoung Kim (Verfasst von), Min‐Soo Kim (Verfasst von)
• Format: Buch
• Veröffentlicht: Wiley, 2024-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract The SARS‐CoV‐2 caused COVID‐19 pandemic has posed a global health hazard. While some vaccines have been developed, protection against viral infection is not perfect because of the urgent approval process and the emergence of mutant SARS‐CoV‐2 variants. Here, we employed UDCA as an FXR antag...